News 2022_06_23_CHMP_Positive_Opinion_PR_FR_Final-1 Home > Safety and efficacy results of LIS1, a new induction treatment in organ transplantation by the French biotech XENOTHERA > 2022_06_23_CHMP_Positive_Opinion_PR_FR_Final-1 23 June 2022
